Market Overview:
The Global Blood Irradiator Market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing demand for blood irradiation in hospitals, blood banks, and research institutions across the globe. In addition, the growing awareness about blood safety and security is also propelling the growth of this market. Based on type, the global blood irradiator market can be segmented into X-ray blood irradiation and gamma-ray blood irradiation. The X-ray segment dominates this market owing to its low cost as compared to gamma radiation therapy and its ability to treat a wide range of pathogens present in donated or stored red cells. Based on application, this market can be divided into three segments: hospitals,blood banks,and research institutions.
Product Definition:
A blood irradiator is a device that uses radiation to sterilize medical equipment and supplies. It is important because it helps to prevent the spread of infection.
X-ray Blood Irradiation:
X-ray Blood Irradiation is a medical procedure wherein the body parts are exposed to X-rays for the treatment of cancer and other diseases. The process takes place in two different ways, namely stationary and moving irradiation. In stationary irradiation, the part is placed in a container filled with X-ray source which is then moved around to target multiple areas of a human body.
Gamma-ray Blood Irradiation:
Blood irradiator is a medical device used to treat cancer and other diseases by delivering high doses of ionizing radiation. It works by using gamma rays for the treatment. The mechanism is that when the blood comes in contact with the tumor it mutates into radioactive material which then goes inside the body and damage any cancer cell which then dies without leaving any harm to surrounding tissues or organs.
Application Insights:
Based on the application, the global market is segmented into blood bank, hospital and research institutions. The blood bank held the largest share of revenue in 2017 owing to its wide applications in storing and transfusing blood across various patient groups. Moreover, it is also used for stem cell preservation which further propels its demand globally.
The gamma-ray Blood Irradiation (GRBI) system finds extensive usage as a sterilization tool for medical devices & equipment which are exposed to biological materials such as human or animal body fluids or tissue samples. It has gained significant popularity due to low cost and easy handling compared to other forms of radiation such as X-ray based systems that are widely used across hospitals worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of blood irradiator manufacturers and suppliers, high adoption rate for technologically advanced products, and increasing demand for blood components across various applications. The U.S., in particular, is one of the major markets for these devices as it has one of the highest per capita usage rates globally along with being among the first countries to adopt new technologies during peacetime situations.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to factors such as growing medical tourism industry due to affordable treatment costs by international patients; rising awareness about available treatments; supportive government initiatives towards improving healthcare infrastructure; and an increase in disposable income that leads consumers towards better health insurance coverage which includes access to advanced radiology services including whole-body imaging using ionizing radiation sources such as radiators for diagnosis purposes.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the key growth drivers for the blood irradiator market. According to a study by the American Cancer Society, it is estimated that around 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and around 600,920 people will die from this disease. This growing prevalence of cancer is expected to drive demand for blood irradiators over the forecast period.
- Rising demand for minimally invasive surgeries: Minimally invasive surgeries are becoming increasingly popular due to their many benefits such as shorter hospital stays, reduced pain and trauma, and faster recovery times when compared with traditional open surgery procedures. This rising demand for minimally invasive surgeries is expected to boost demand for blood irradiators over the forecast period as they are used extensively in these procedures to sterilize surgical instruments and other equipment used during surgery.
- Growing number of transplantations: The number of organ transplants being performed worldwide has been increasing at a rapid pace in recent years due to advances in medical technology and an increase in awareness about organ donation among patients and their families alike .This growing trend is expected to fuel demand for blood irradiators over the forecast period as they are extensively used prior to transplantation operationsto kill any potential pathogens or viruses present in donated organs or tissues .
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Irradiator Market Research Report
By Type
X-ray Blood Irradiation, Gamma-ray Blood Irradiation
By Application
Blood Bank, Hospital, Research Institutions
By Companies
Best Theratronics, Gamma-Service, Gilardoni, Hitaci, Cegelec, Rad Source, Shinva Medical, NPIC, CIF medical, JL Shepherd and Associates
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Blood Irradiator Market Report Segments:
The global Blood Irradiator market is segmented on the basis of:
Types
X-ray Blood Irradiation, Gamma-ray Blood Irradiation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Bank, Hospital, Research Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Best Theratronics
- Gamma-Service
- Gilardoni
- Hitaci
- Cegelec
- Rad Source
- Shinva Medical
- NPIC
- CIF medical
- JL Shepherd and Associates
Highlights of The Blood Irradiator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- X-ray Blood Irradiation
- Gamma-ray Blood Irradiation
- By Application:
- Blood Bank
- Hospital
- Research Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Irradiator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A blood irradiator is a medical device that uses radiation to treat cancer. It emits high-energy beams of radiation that damage or kill cancer cells.
Some of the major companies in the blood irradiator market are Best Theratronics, Gamma-Service, Gilardoni, Hitaci, Cegelec, Rad Source, Shinva Medical, NPIC, CIF medical, JL Shepherd and Associates.
The blood irradiator market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Irradiator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Blood Irradiator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Blood Irradiator Market - Supply Chain
4.5. Global Blood Irradiator Market Forecast
4.5.1. Blood Irradiator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Blood Irradiator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Blood Irradiator Market Absolute $ Opportunity
5. Global Blood Irradiator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Blood Irradiator Market Size and Volume Forecast by Type
5.3.1. X-ray Blood Irradiation
5.3.2. Gamma-ray Blood Irradiation
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Blood Irradiator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Blood Irradiator Market Size and Volume Forecast by Application
6.3.1. Blood Bank
6.3.2. Hospital
6.3.3. Research Institutions
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Blood Irradiator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Blood Irradiator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Blood Irradiator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Blood Irradiator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Blood Irradiator Demand Share Forecast, 2019-2029
9. North America Blood Irradiator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Blood Irradiator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Blood Irradiator Market Size and Volume Forecast by Application
9.4.1. Blood Bank
9.4.2. Hospital
9.4.3. Research Institutions
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Blood Irradiator Market Size and Volume Forecast by Type
9.7.1. X-ray Blood Irradiation
9.7.2. Gamma-ray Blood Irradiation
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Blood Irradiator Demand Share Forecast, 2019-2029
10. Latin America Blood Irradiator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Blood Irradiator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Blood Irradiator Market Size and Volume Forecast by Application
10.4.1. Blood Bank
10.4.2. Hospital
10.4.3. Research Institutions
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Blood Irradiator Market Size and Volume Forecast by Type
10.7.1. X-ray Blood Irradiation
10.7.2. Gamma-ray Blood Irradiation
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Blood Irradiator Demand Share Forecast, 2019-2029
11. Europe Blood Irradiator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Blood Irradiator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Blood Irradiator Market Size and Volume Forecast by Application
11.4.1. Blood Bank
11.4.2. Hospital
11.4.3. Research Institutions
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Blood Irradiator Market Size and Volume Forecast by Type
11.7.1. X-ray Blood Irradiation
11.7.2. Gamma-ray Blood Irradiation
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Marke Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Blood Irradiator Demand Share, 2019-2029
12. Asia Pacific Blood Irradiator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Blood Irradiator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Blood Irradiator Market Size and Volume Forecast by Application
12.4.1. Blood Bank
12.4.2. Hospital
12.4.3. Research Institutions
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Blood Irradiator Market Size and Volume Forecast by Type
12.7.1. X-ray Blood Irradiation
12.7.2. Gamma-ray Blood Irradiation
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Blood Irradiator Demand Share, 2019-2029
13. Middle East & Africa Blood Irradiator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Blood Irradiator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Blood Irradiator Market Size and Volume Forecast by Application
13.4.1. Blood Bank
13.4.2. Hospital
13.4.3. Research Institutions
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Blood Irradiator Market Size and Volume Forecast by Type
13.7.1. X-ray Blood Irradiation
13.7.2. Gamma-ray Blood Irradiation
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Blood Irradiator Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Blood Irradiator Market: Market Share Analysis
14.2. Blood Irradiator Distributors and Customers
14.3. Blood Irradiator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Best Theratronics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Gamma-Service
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Gilardoni
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hitaci
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cegelec
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Rad Source
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shinva Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. NPIC
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. CIF medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. JL Shepherd and Associates
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
